Arkolith/Insider Trading/RANI/Form 4

Rometty Lisa Ann

DirectorRani Therapeutics Holdings, Inc. (RANI) · full profile →Form 4 · filed Dec 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2023Disposed to issuer(D)101K——0
Dec 16, 2023Grant(A)18K——18K
Dec 16, 2023Disposed to issuer(D)18K——31K
Dec 16, 2023Grant(A)101K——101K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-071466) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML